Literature DB >> 1500202

Results of the third immunology of leprosy/immunology of tuberculosis antimycobacterial monoclonal antibody workshop.

S Khanolkar-Young1, A H Kolk, A B Andersen, J Bennedsen, P J Brennan, B Rivoire, S Kuijper, K P McAdam, C Abe, H V Batra.   

Abstract

An international workshop was sponsored by the World Health organization to screen new antimycobacterial monoclonal antibodies and to identify antibodies which could be recommended as standard reagents giving consistent results under differing assay conditions. Fifty-eight antibodies were submitted to the workshop by eight independent laboratories. Nineteen of the antibodies recognized antigens distinct from those identified in earlier workshops, defining at least 10 new protein antigens. Monoclonal antibodies characterized in the workshop provide a set of convenient reagents for further characterization of mycobacterial antigens.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500202      PMCID: PMC257412          DOI: 10.1128/iai.60.9.3925-3927.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Mycobacterial glycolipids: isolation, structures, antigenicity, and synthesis of neoantigens.

Authors:  M McNeil; D Chatterjee; S W Hunter; P J Brennan
Journal:  Methods Enzymol       Date:  1989       Impact factor: 1.600

2.  Results of a World Health Organization-sponsored workshop on monoclonal antibodies to Mycobacterium leprae.

Authors: 
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

3.  Results of a World Health Organization-sponsored workshop to characterize antigens recognized by mycobacterium-specific monoclonal antibodies.

Authors: 
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

4.  Most Mycobacterium leprae carbohydrate-reactive monoclonal antibodies are directed to lipoarabinomannan.

Authors:  H Gaylord; P J Brennan; D B Young; T M Buchanan
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

5.  The major native proteins of the leprosy bacillus.

Authors:  S W Hunter; B Rivoire; V Mehra; B R Bloom; P J Brennan
Journal:  J Biol Chem       Date:  1990-08-25       Impact factor: 5.157

6.  Dissection of Mycobacterium tuberculosis antigens using recombinant DNA.

Authors:  R A Young; B R Bloom; C M Grosskinsky; J Ivanyi; D Thomas; R W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

7.  Antigens in culture supernatant of Mycobacterium tuberculosis: epitopes defined by monoclonal and human antibodies.

Authors:  A Verbon; S Kuijper; H M Jansen; P Speelman; A H Kolk
Journal:  J Gen Microbiol       Date:  1990-05

8.  Structure and mapping of antigenic domains of protein antigen b, a 38,000-molecular-weight protein of Mycobacterium tuberculosis.

Authors:  A B Andersen; E B Hansen
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

9.  Stress proteins are immune targets in leprosy and tuberculosis.

Authors:  D Young; R Lathigra; R Hendrix; D Sweetser; R A Young
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

10.  Rapid identification of cultured Mycobacterium tuberculosis with a panel of monoclonal antibodies in western blot and immunofluorescence.

Authors:  C P Verstijnen; R Schöningh; S Kuijper; J Bruins; R J von Ketel; D G Groothuis; A H Kolk
Journal:  Res Microbiol       Date:  1989 Nov-Dec       Impact factor: 3.992

View more
  14 in total

Review 1.  Clinical utility of serodiagnosis of tuberculosis.

Authors:  S Mahadevan
Journal:  Indian J Pediatr       Date:  1997 Jan-Feb       Impact factor: 1.967

2.  Mass spectrometric identification of mtb81, a novel serological marker for tuberculosis.

Authors:  R C Hendrickson; J F Douglass; L D Reynolds; P D McNeill; D Carter; S G Reed; R L Houghton
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  Mapping and identification of the major cell wall-associated components of Mycobacterium leprae.

Authors:  M A Marques; S Chitale; P J Brennan; M C Pessolani
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Use of a whole blood assay to evaluate in vitro T cell responses to new leprosy skin test antigens in leprosy patients and healthy subjects.

Authors:  R E Weir; P J Brennan; C R Butlin; H M Dockrell
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

5.  A mycobacterial extracytoplasmic sigma factor involved in survival following heat shock and oxidative stress.

Authors:  N D Fernandes; Q L Wu; D Kong; X Puyang; S Garg; R N Husson
Journal:  J Bacteriol       Date:  1999-07       Impact factor: 3.490

6.  Characterization of phylogenetically distant members of the adenylate cyclase family from mycobacteria: Rv1647 from Mycobacterium tuberculosis and its orthologue ML1399 from M. leprae.

Authors:  Avinash R Shenoy; Nandini P Sreenath; Mohana Mahalingam; Sandhya S Visweswariah
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

7.  Definition of Mycobacterium tuberculosis culture filtrate proteins by two-dimensional polyacrylamide gel electrophoresis, N-terminal amino acid sequencing, and electrospray mass spectrometry.

Authors:  M G Sonnenberg; J T Belisle
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

8.  Human humoral responses to antigens of Mycobacterium tuberculosis: immunodominance of high-molecular-mass antigens.

Authors:  S Laal; K M Samanich; M G Sonnenberg; S Zolla-Pazner; J M Phadtare; J T Belisle
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

9.  Search for the molecular basis of morphological variation in Mycobacterium avium.

Authors:  S Prinzis; B Rivoire; P J Brennan
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

10.  Serological distinction of integral plasma membrane proteins as a class of mycobacterial antigens and their relevance for human T cell activation.

Authors:  J Mehrotra; D Bisht; V D Tiwari; S Sinha
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.